ACE and Alzheimer disease: We investigated hypertensive AD patients taking ACE inhibitors (<i>n</i> = 55) or other anti-hypertensive medications (<i>n</i> = 57) at baseline and one year later, along with age-matched controls (<i>n</i> = 64) and normotensive AD patients (<i>n</i> = 61).